Records containing: Localized Non-Resectable Adult Liver Carcinoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2021-09-05
Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study
CLINICAL_TRIALS study record update · 2020-01-22
A Pilot Study of Stereotactic Liver Irradiation for Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2019-01-25
A Phase 2 Trial of Temsirolimus and Bevacizumab in Patients With Endometrial, Ovarian, Hepatocellular Carcinoma, Carcinoid or Islet Cell Cancer
CLINICAL_TRIALS study record update · 2017-08-10
Randomized Phase II Trial of Single Agent MEK Inhibitor Trametinib (GSK1120212) Vs 5-Fluorouracil or Capecitabine in Refractory Advanced Biliary Cancer
CLINICAL_TRIALS study record update · 2016-05-12
A Phase I Trial of Escalating Doses of the Anti-IGF-1R Monoclonal Antibody IMC-A12 and Standard Dose Sorafenib for Treatment of Advanced Hepatocellular Carcinoma
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2016-04-15
A Multi-Institutional Phase II Study of the Akt Inhibitor MK-2206 in Refractory Biliary Cancers
CLINICAL_TRIALS study record update · 2015-10-19
MR Techniques in the Evaluation of Hepatocellular Carcinoma: Gadoxetate
CLINICAL_TRIALS study record update · 2015-10-05
A Phase II Study of MK-2206 in Patients With Advanced Hepatocellular Carcinoma Who Have Failed or Are Intolerant of One Prior Line of Anti-angiogenic Therapy
CLINICAL_TRIALS study record update · 2015-07-02
Phase I Pharmacokinetic Study of Dasatinib (BMS-354825) (NSC-732517) in Patients With Advanced Malignancies and Varying Levels of Liver Dysfunction